EXFO reports higher-than-expected 2Q 2019 earnings as Astellia acquisition pays off

The mobile solutions company acquired France’s Astellia last year to boost analytics expertise

5G diagram
The company develops testing, monitoring and analytics solutions for communications providers

EXFO Inc (TSE:EXF) (NASDAQ:EXFO), which develops testing, monitoring and analytics solutions for communications providers, announced higher-than-expected 2Q 2019 earnings on Tuesday thanks to a nearly 14% increase in sales for the quarter.

Sales increased more than 14% to US$74 million year-over-year in large part due to a full-quarter contribution from the Quebec-based company’s 2018 acquisition of Astellia, a mobile network performance analysis company.

In 2Q 2019, EXFO reported net earnings of US$5.2 million, or $0.09 per share, as compared to a loss of $4.6 million or $0.04 during the year-ago period.

Earnings beat expectations

Analysts on average were expecting earnings per share of $0.08.

"EXFO delivered outstanding second quarter results with strong revenue and bookings growth, profitability and cash flow generation—all encouraging signs for our T&M and SASS product families and the leverage in our operating model," said EXFO's CEO Philippe Morin. "Clearly, EXFO is on track with its profitable growth strategy amid a rapidly transforming industry.

In 3Q 2019 EXFO is forecasting sales of around US$70 million, yet a projected net loss of $0.04 per share.

EXFO’s shares were up more than 4% to C$5.12 at the close Tuesday in Toronto, and nearly 5% to US$3.86 in the US.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: EXFO

Price: 5.155 CAD

Market: TSX
Market Cap: $287.11 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Arcadia Biosciences reports strong 2Q revenue despite coronavirus impact

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matthew Plavan tells Proactive the California-based group's 2Q revenue growth was fueled by GLA sales and GoodWheat royalties. Plavan says the company also cinched a trio of recent GoodWheat agreements: a collaboration with Corner Foods to bring its...

3 hours, 2 minutes ago

2 min read